- Home
- SLQT vs KROS Comparison
SLQT vs KROS Comparison
Compare SLQT & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SLQT | KROS |
|---|---|---|
| Founded | 1999 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 281.6M | 655.9M |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SLQT | KROS |
|---|---|---|
| Price | $1.39 | $21.36 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 12 |
| Target Price | $3.88 | ★ $22.20 |
| AVG Volume (30 Days) | 878.2K | ★ 1.0M |
| Earning Date | 02-09-2026 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.57 |
| Revenue | ★ $1,563,142,000.00 | $246,718,000.00 |
| Revenue This Year | $13.00 | $6,876.34 |
| Revenue Next Year | $7.65 | N/A |
| P/E Ratio | ★ N/A | $12.87 |
| Revenue Growth | 13.16 | ★ 37798.31 |
| 52 Week Low | $1.33 | $9.12 |
| 52 Week High | $6.86 | $22.55 |
Technical Indicators
Market Signals| Indicator | SLQT | KROS |
|---|---|---|
| Relative Strength Index (RSI) | 41.99 | 64.94 |
| Support Level | $1.33 | $19.76 |
| Resistance Level | $1.46 | $21.75 |
| Average True Range (ATR) | 0.08 | 1.10 |
| MACD | 0.01 | -0.10 |
| Stochastic Oscillator | 21.74 | 78.47 |
Price Performance
Historical ComparisonAbout SLQT SelectQuote Inc.
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.